Aytu Biopharma (AYTU) EBITDA (2010 - 2026)
Aytu Biopharma's EBITDA was $344,000 in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$6.16 million a year earlier.
Analysis
Aytu Biopharma (AYTU) EBITDA (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), EBITDA at Aytu Biopharma came in at -$4.39 million.
- In earlier fiscal years, EBITDA was -$2.45 million in FY2025, $5.13 million in FY2024, -$8.25 million in FY2023 and -$99.76 million in FY2022.
- The fiscal Q4 2026 figure marks the highest quarterly EBITDA since fiscal Q3 2025.
- Per Business Quant data, AYTU's EBITDA in the three fiscal quarters before Q4 2026 was -$2.94 million (Q3 2026), -$1.09 million (Q2 2026) and -$701,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Aytu Biopharma | 24.76 Mn | -90.92 Mn | 10.41 Mn | 372,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 372,000.00 |
| Mar 31, 2026 | -2.92 Mn |
| Dec 31, 2025 | -1.06 Mn |
| Sep 30, 2025 | -672,000.00 |
| Jun 30, 2025 | -6.13 Mn |
| Mar 31, 2025 | 3.74 Mn |
| Dec 31, 2024 | -375,000.00 |
| Sep 30, 2024 | 431,000.00 |
| Jun 30, 2024 | -581,000.00 |
| Mar 31, 2024 | 97,000.00 |
| Dec 31, 2023 | 4.70 Mn |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | 2.43 Mn |
| Mar 31, 2023 | -6.27 Mn |
| Dec 31, 2022 | -4.49 Mn |
| Sep 30, 2022 | 638,000.00 |
| Jun 30, 2022 | -14.58 Mn |
| Mar 31, 2022 | -50.75 Mn |
| Dec 31, 2021 | -8.78 Mn |
| Sep 30, 2021 | -25.18 Mn |
API Access
Aytu Biopharma EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=AYTU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();